Tagged with B

Bulgaria Peter Velev, chairman and CEO at Ecopharm, gives an update of the success of his generics company, Ecopharm, and introduces its new digital platform, Credoweb, created to accompany the pharmaceutical industry in the new era of digitalization. Before introducing Credoweb to our international audience, can you present yourself as well…

Switzerland Rocco Donnino, executive vice president of corporate development of AppRiver AG, a cybersecurity company with headquarters in Switzerland and Florida, US, discusses the strategic steps in establishing AppRiver across Europe and the services they provide, specifically the layered security approach portrayed throughout the healthcare and life science sector. Furthermore, he…

Canada Clarissa Desjardins is the founder and CEO since 2011 of Canadian biotech success story, Clementia Pharmaceuticals. She explains the different milestones of her company and her priorities moving forward. She also gives her insights on the entrepreneurship environment in Canada and advice on how to make it even more compelling…

Bulgaria Ivan Kolev, country manager at Wörwag Pharma Bulgaria, explains how has the affiliate performed over the last years as well as shares an overview about the development of diabetes and its complications, and pain management in the country. You have had two different stages at Wörwag Pharma; working in Actavis…

Brazil Samuel Mauricio, vice-president for Brazil at Octapharma, one of the largest human protein manufacturers in the world, provides an insightful analysis of the Brazilian plasma market, demonstrating Octapharma’s remarkable willingness to further position itself as the partner of choice for the country’s public healthcare system. As the head of the…

Ukraine Ukraine’s bold decision to outsource public procurement of medicines to international agencies to combat rampant corruption has been well received by the pharma MNCs operational in the country, but faces criticism from domestic players. “Healthcare procurement was widely considered as one of the areas most seriously altered by corruption” Tetiana…

Brazil Nelson Mussolini, executive president of the syndicate of the pharmaceutical industry in the State of Sao Paulo (Sindusfarma), which represents around 95 percent of all pharmaceutical marketing in the country and gathers together over 312 associate members overall, documents the exceptional growth of the pharmaceutical industry in Brazil despite the…

Bulgaria Vladimir Afenliev, chief director business operations, strategic and organizational developments at Sopharma, explains the great success of the strongest Bulgarian pharmaceutical company in the country as well as the upcoming strategies to further grow Sopharma in the region. Sopharma is the most important pharmaceutical group in Bulgaria with activities spanning…

Bulgaria Yavor Kostov, country manager at Mylan in Bulgaria, discloses his strategies to successfully lead an affiliate through corporate changes and explains the important mission of Mylan to provide high-quality treatments to people around the world in general and Bulgaria in particular.  As you are a medical doctor by training, what…

Brazil Antonio Britto, the executive president of Interfarma, the main association gathering together local and international innovators in Brazil, provides insights into some of the hottest topics in Brazil’s pharmaceutical sector, including an assessment of the eye-catching growth prospects of the industry after years of political and economy turmoil, as well…

Brazil Eduardo Martins, president director of Pharlab, provides insights into the “2020 vision” that has been driving the eye-catching development of this ambitious domestic company and documents how Pharlab is leveraging the expertise and added value brought by France’s Biogaran, the company’s new owners, to sharpen its competitive advantage in the…

Austria Gerhard Hirczi of the Vienna Business Agency and Peter Halwachs of LISAvienna describe Vienna’s impressive footprint in the life sciences, its positioning as the start-up hub for Central and Eastern Europe, and the potential ramifications of the European Medicines Agency (EMA) relocating to the city. Could you please start by…